Quality of Life
Conditions
Brief summary
A multicenter longitudinal study with data collection at 4 and 8 months after hospital discharge.
Detailed description
The study population consisted of patients treated with NIV/CPAP, admitted to the COVID-19 wards of the AO SS Antonio e Biagio and Cesare Arrigo in Alessandria (the promoting center), the Azienda Sanitaria Locale Bt (Barletta, Andria, Trani) and the Azienda Socio Sanitaria Territoriale in Lecco, from November 2020 to June 2021. The study assessed at 4 and 8 months after hospital discharge in the patient's home environment, quality of life, residual disability, anxiety and insomnia. Enrollment took place only after the approval of the Ethics Committee of each participating center.
Interventions
administration of questionnaires
Sponsors
Study design
Eligibility
Inclusion criteria
All patients aged ≥18 years admitted for COVID-19 pneumonia treated with NIV/CPAP, discharged to their home with a negative molecular swab and signed informed consent were included in the study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| COVID-19 qualità di vita | 8 mesi | polmonite COVID-19 qualità di vita |
Countries
Italy